Trademark applications and grants for Kymera Therapeutics, Inc.. Kymera Therapeutics, Inc. has 12 trademark applications. The latest application filed is for "IRAKIMID"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 200 Arsenal Yards Blvd, Suite 230 Watertown, MASSACHUSETTS UNITED STATES 02472 |
Patent Application | Date |
---|---|
TRICYCLIC CRBN LIGANDS AND USES THEREOF 20220306631 - 17/679496 JI; Nan ;   et al. | 2022-09-29 |
FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF 20220281831 - 17/597628 JI; Nan ;   et al. | 2022-09-08 |
IRAK4 DEGRADERS AND USES THEREOF 20220274993 - 17/651202 RONG; Haojing ;   et al. | 2022-09-01 |
IRAK4 DEGRADERS AND USES THEREOF 20220273668 - 17/651201 GOLLOB; Jared ;   et al. | 2022-09-01 |
METHODS OF TREATING MUTANT LYMPHOMAS 20220054453 - 17/444015 Walker; Duncan | 2022-02-24 |
NCAGE Code | 8LPH6 | KYMERA THERAPEUTICS, INC. |
CAGE Code | 8LPH6 | KYMERA THERAPEUTICS, INC. |
SEC | 0001815442 | Kymera Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.